Please note that the contents in this webpage are current as of the date of the announcement and the information including but not limited to the product availability, specification, prices, contacts, are subject to change without prior notice.
- Sep 9, 2021
- Fujifilm launches a project for verifying the effectiveness of AI technology assisting diagnostic imaging in health screening services in India
- Sep 7, 2021
-
Fujifilm Launches LTO Ultrium9 Data Cartridge
-Magnetic tape storage media with maximum storage capacity of 45TB
-Providing safe long-term storage of high-volume data at low cost
-Significantly mitigating CO2 emissions - Sep 2, 2021
- Fujifilm launches mirrorless digital camera “FUJIFILM GFX50S II”
- Sep 2, 2021
- Fujifilm launches FUJINON Lens GF35-70mmF4.5-5.6 WR
- Sep 2, 2021
- Fujifilm unveils the latest development roadmap for interchangeable lenses for the GFX Series of mirrorless digital cameras
- Sep 2, 2021
- Fujifilm launches mirrorless digital camera “FUJIFILM X-T30 II”
- Sep 2, 2021
- Fujifilm launches FUJINON Lens XF23mmF1.4 R LM WR
- Sep 2, 2021
- Fujifilm launches FUJINON Lens XF33mmF1.4 R LM WR
- Sep 2, 2021
- Fujifilm unveils the latest development roadmap for interchangeable lenses for the X Series of mirrorless digital cameras
- Sep 2, 2021
- Transfer of FUJIFILM Toyama Chemical's Radiopharmaceutical Business to PeptiDream
- Aug 31, 2021
- Launch of Therapeutic Radiopharmaceutical Product, Lutathera® Injection targeting neuroendocrine tumors in Japan (FUJIFILM Toyama Chemical)
- Jul 6, 2021
- FUJIFILM Holdings adopts a “DX Vision” (FUJIFILM Holdings)
- Jun 29, 2021
- $850 Million USD (¥90 Billion Yen) investment in FUJIFILM Diosynth Biotechnologies to add additional development and manufacturing capacity
- Jun 23, 2021
-
Marketing Authorization Granted for Lutathera® Injection in Japan
- The first approval in Japan for peptide receptor radionuclide treatment drug, providing a new therapeutic option for neuroendocrine tumors (FUJIFILM Toyama Chemical) - May 27, 2021
- FUJIFILM Wako Pure Chemical launches “E484Q mutation detection kit” reagent for detecting a SARS-CoV-2 mutation (FUJIFILM Wako Pure Chemical)
- May 18, 2021
- BlueRock Therapeutics, FUJIFILM Cellular Dynamics, and Opsis Therapeutics Enter into a Strategic R&D Alliance to Discover and Develop Cell Therapies for Eye Diseases
- May 17, 2021
- FUJIFILM Wako Pure Chemical launches mutation detection kit for SARS-CoV-2 “L452R” (FUJIFILM Wako Pure Chemical)